Teva Pharmaceutical Industries Limited

TEVANYSEHealthcare● Active

$34.19

$-0.24(-0.70%)

Market Cap$39.8B

P/E Ratio—

52W High$37.35

52W Low$14.99

Avg Volume6.7M

Open$34.30

Beta0.85

Revenue Financials Earnings

Teva Pharmaceutical Industries Limited (TEVA) Revenue

Annual & quarterly revenue history · segment & region breakdown

TEVA · revenue · updated Jun 8, 2026

Core revenue metrics

Trailing 12 months

Teva Pharmaceutical Industries Limited trailing twelve-month (TTM) revenue is $17.35B, an increase of 4.31% year-over-year from $17.26B in FY2025.

TTM revenue

$17.35B

4-quarter sum · USD

YoY growth

+4.31%

vs FY2025 $17.26B

Price / sales

2.29×

mktCap ÷ TTM rev

Revenue per day

$48M

Est. TTM ÷ 365

Revenue / employee

$469K

37000 employees

FY2025

$17.26B

FY2024

$16.54B

5Y CAGR

+1.7%

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · Teva Pharmaceutical Industries Limited SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

2025 – 2006 · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth
2025-12-31	$17.26B	+$0.71B	+4.31%
2024-12-31	$16.54B	+$0.70B	+4.41%
2023-12-31	$15.85B	+$0.92B	+6.16%
2022-12-31	$14.93B	-$0.95B	-6.00%
2021-12-31	$15.88B	-$0.78B	-4.69%
2020-12-31	$16.66B	-$0.23B	-1.35%
2019-12-31	$16.89B	-$1.97B	-10.43%
2018-12-31	$18.85B	-$3.53B	-15.77%
2017-12-31	$22.39B	+$0.48B	+2.20%
2016-12-31	$21.90B	+$2.25B	+11.45%

TEVA revenue by year · TEVA revenue history · TEVA annual revenue data

Compare revenue vs peers

Drug Manufacturers - Specialty & Generic

Compare TEVA revenue against listed peers. Click any row to open that company's revenue tab.

Koninklijke Philips N.V.

Revenue breakdown

Segment & Geography

By business segment

$14.6B84.6%

$1.55B9.0%

$0.68B3.9%

$0.42B2.5%

By geography

$9.19B56.1%

$5.04B30.8%

$2.16B13.2%

Data from Teva Pharmaceutical Industries Limited annual 10-K filing · FY ending 2025-12-31

TEVA revenue breakdown · TEVA revenue by segment · TEVA revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Teva Pharmaceutical Industries Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Teva Pharmaceutical Industries Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Teva Pharmaceutical Industries Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

TEVA revenue · 4 questions

TEVA's trailing twelve-month (TTM) revenue is $17.35B. That is an increase of 4.31% year-over-year from $17.26B in FY2025.

TEVA revenueTEVA annual revenuewhat is TEVA revenueTEVA TTM revenue

▸ Source: FMP · Teva Pharmaceutical Industries Limited SEC filings · GAAP · Teva Pharmaceutical Industries Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026